On October 20, 2008, the Food and Drug Administration (FDA) released a public health notification concerning the serious complications associated with transvaginal placement of surgical mesh in repair of Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). The FDA’s notification informed the public of the possible health risks associated with the treatment, recommended steps for physicians, and how to report an issue that has occurred because of surgical mesh. Despite the warnings released in 2008, the FDA reported in 2010 that around 300,000 women underwent surgeries to repair POP using the controversial product. Around 80 percent of 260,000 surgeries ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.